Companies: 10,795·Total market cap: $144.5T
The Hempshire Group, Inc.

The Hempshire Group, Inc.

HMPSFOTCHealthcare
$0.19
+$0.00(+0.00%)
Market Cap$15681177
P/E Ratio
52W High$0.1928
52W Low$0.1928

The Hempshire Group, Inc. (HMPSF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

hmpsf · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for The Hempshire Group, Inc. (HMPSF) measures how much investors pay for each dollar of the company's trailing earnings. HMPSF's current PE ratio of N/A is calculated by dividing its stock price of $0.19 by its TTM earnings per share of -$0.10.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
EPS (TTM)
-$0.10
TTM · diluted EPS
PEG Ratio
-0.03
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · The Hempshire Group, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2020 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
The Hempshire Group, Inc.
The Hempshire Group, Inc.You
HMPSF
$16MN/A-$0.10
American Hemp Ventures, Inc.
American Hemp Ventures, Inc.
AMHV
$16MN/A
Antisense Therapeutics Limited
Antisense Therapeutics Limited
ATHJF
$20MN/A-$0.01
Biofrontera AG
Biofrontera AG
BFFTF
$19MN/A-$13.02
TPCO Holding Corp.
TPCO Holding Corp.
GRAMF
$20MN/A-$2.32
MGC Pharmaceuticals Limited
MGC Pharmaceuticals Limited
MGCLF
$12MN/A-$7.07
Lifeist Wellness Inc.
Lifeist Wellness Inc.
NXTTF
$16MN/A

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 3 of 3 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-0.10
2021-12-31
FY2021
$-0.03
2020-12-31
FY2020
$-0.03

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for The Hempshire Group, Inc. (HMPSF) measures how much investors pay for each dollar of the company's trailing earnings. HMPSF's current PE ratio of N/A is calculated by dividing its stock price of $0.19 by its TTM earnings per share of -$0.10.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.19 ÷ -$0.10 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

HMPSF pe ratio · 6 questions

HMPSF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.19 and TTM EPS of -$0.10. Data sourced from Financial Modeling Prep via HMPSF's SEC 10-K and 10-Q filings.

HMPSF PE ratioWhat is HMPSF PE ratioCurrent PE ratio of HMPSFHMPSF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · The Hempshire Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09